Dr Lal PathLabs Q1FY25 results: Net profit rises 28% to Rs 106 cr

Consolidated net profit rose 28 per cent to Rs 106 cr (around $13 million) for the quarter ended June 30, beating analysts' estimate of Rs 99.27 cr, per LSEG

Bs_logo — The company, which operates about 300 labs in the country said its number of samples tested climbed 9.3 per cent | Image: Wikimedia Commons

Dr Pathlab, Dr lal pathlabs, medical test — The company, which operates about 300 labs in the country said its number of samples tested climbed 9.3 per cent | Image: Wikimedia Commons

1 min read Last Updated : Aug 07 2024 | 6:09 PM IST

Dr Lal PathLabs on Wednesday said its consolidated profit after tax increased 29 per cent to Rs 108 crore for the first quarter ending June 30, 2024.

The company had reported a profit after tax of Rs 84 crore in the April-June quarter of the last fiscal.

Revenue rose to Rs 602 crore for the period under review as compared to Rs 541 crore in the June quarter of last fiscal, Dr Lal PathLabs said in a statement.

The company said its board has approved an interim dividend of Rs 6 per share for 2024-25.

Shares of the company on Wednesday ended 3.17 per cent up at Rs 3,268.85 apiece on the BSE.

Connect with us on WhatsApp

Uno Minda Ltd Q1FY25 results: Net profit jumps 17% to Rs 210.8 cr

Asian Granito India Q1 results: Sales up 3% to Rs 343 cr, PAT at Rs 30 lakh

Blue Star Q1 result: Profit up two-fold at Rs 168.76 cr, revenue up 28.7%

Lupin Q1 result: Profit jumps 77% to Rs 801 cr on strong performance

Vedanta Q1 FY25 results: Net profit rises 36.6% to Rs 3,606 crore

Topics :Dr Lal PathLabs medical test Q1 results corporate earnings healthcare Healthcare sector

First Published: Aug 07 2024 | 4:38 PM IST